Essential
Everything you need to get started.
Starting from€299
Included
Get a quote - Data logger rental
- Calibrated data loggers
- Calibration certificates
GMP temperature mapping for pharma and biotech
Commissioning a new GMP facility, preparing an EMA, FDA or MHRA inspection, or under change control after an HVAC modification? A temperature mapping study by Temperature Mapping Europe provides the Annex 15-aligned OQ/PQ evidence your Qualified Person and auditors expect, for production rooms, climate and stability chambers, cold rooms 2-8 °C, and freezers down to -80 °C.
In brief
GMP temperature mapping is a documented qualification study that measures whether every product location and worst-case position inside a production room, climate chamber, cold room or freezer stays within its required temperature range under representative loading. The study provides Annex 15-aligned OQ/PQ evidence, identifies hot and cold spots, justifies the fixed monitoring probe position and alarm limits, and traces acceptance criteria back to the URS and forward to the routine monitoring plan.
Temperature mapping, your way.
Most popular
Professional
Expert support from start to finish.
Starting from€599+ logger rental
Included
Get a quote - Data logger rental
- Calibrated data loggers
- Calibration certificates
- Mapping protocol
- Data analysis
- Hot & cold spot identification
- Expert mapping report
- Ready for audit
Complete
Fully managed, from start to finish.
Starting from€999+ logger rental
Included
Get a quote - Data logger rental
- Calibrated data loggers
- Calibration certificates
- Mapping protocol
- Data analysis
- Hot & cold spot identification
- Expert mapping report
- Ready for audit
- Complete on-site execution
Three questions a GMP auditor will ask about your qualified space
A mapping study is not an end in itself. It exists to give the Qualified Person and the inspector a well-supported answer to the three questions that come up in almost every GMP inspection of a controlled temperature environment.
"Show me the OQ and PQ mapping. How do the acceptance criteria trace to the URS?"
Annex 15 requires a documented chain from user requirements, through OQ in the unloaded state and PQ under representative loading, to routine monitoring. The mapping dossier makes that chain explicit: the URS states the required temperature range, the protocol translates it into acceptance criteria with justified guard band, and the report shows every product location compliant with specification. A less complete evidence chain can appear as a gap in the qualification lifecycle.
"How do you know the representative loaded worst case is covered, not just the empty chamber?"
An empty-chamber OQ demonstrates intrinsic uniformity but says little about production reality. A stability chamber loaded with product to 80 percent shelf capacity, a cold room after a full pallet delivery, a production room during peak occupancy: that is where temperature excursions occur. Mapping under representative loading is the PQ evidence that inspectors ask to see, and where CAPA is initiated when acceptance criteria are not met.
"How did the mapping data translate into the monitoring probe position and alarm limits?"
Without mapping, the monitoring probe usually sits where the OEM technician placed it, and the alarm limits are derived directly from labelled storage limits, with no additional margin. Mapping replaces both with data: the probe is placed at the actual worst-case position, or the existing position is justified using the mapping data, and alarm limits include a guard band derived from measurement uncertainty and mapping variability. That is what a QP signs off on, and what an inspector wants to see documented.
Test your own qualification file against the auditor's questions
The three questions above are the start. Our free audit-readiness check runs your temperature-mapping and monitoring documentation past the points that GMP and GDP inspectors actually examine, tailored to your room type: production room, climate chamber, cold room, freezer or ULT. In five to ten minutes you receive a PDF report showing where your file is strong, and where an inspector might raise a finding.
Grounded in EU GMP Annex 15, the revised Annex 1 (2023), ICH Q9/Q10, WHO TRS 961 Annex 9 and the ISPE Good Practice Guide: Controlled Temperature Chamber Mapping and Monitoring, plus 37 concrete findings from 58 Dutch GDP/GMP inspection reports.
Delivered by professionals with GMP quality-system experience
At Temperature Mapping Europe, your qualification study is handled by professionals with experience both in pharmaceutical quality systems and in the practical execution of qualification protocols under a maintained validation master plan.
EU-GMP and GDP quality management experience
We have extensive hands-on experience in quality management within EU-GMP/GDP environments for pharmaceutical manufacturing and distribution. This experience includes serving as a Responsible Person / Designated Person and leading validation and qualification programmes in highly regulated environments. That means the dossier speaks the language a QP, an internal QA reviewer and an EMA, FDA or MHRA inspector expect.
Practical and risk-based
The people assessing your production room, chamber or cold storage come from industry. They understand both ICH Q9 quality risk management on paper and how mapping deviations are actually classified, investigated and closed under CAPA in a working GMP facility.
Vendor-neutral
Temperature Mapping Europe is an independent company, not a manufacturer, distributor or label of any equipment supplier. We sell no monitoring systems of our own and choose data loggers on a brand-neutral basis. Our approach follows ISPE, WHO, GDP, GMP and Annex 15 guidance, independent of any supplier.
Personal approach
The same person defines the measurement setup, executes the study, processes the data and writes the report. That gives you short lines, fast planning and one fixed point of contact for the entire qualification cycle.
Annex 15-aligned. Delivered by industry professionals.
What gets measured, and how much of it
The number of loggers, the study duration and the risk zones depend on which storage or processing condition applies, and on the stage of the qualification lifecycle applicable to the space (empty OQ, loaded PQ, or periodic requalification). Below is the typical scope for GMP-controlled temperature environments; the exact plan is defined in the mapping protocol using a risk-based rationale in accordance with ICH Q9, WHO TRS 961 Annex 9 and the ISPE Good Practice Guide: Controlled Temperature Chamber Mapping and Monitoring.
Climate and stability chambers, cold rooms, freezers
For refrigerated APIs, active substance, finished product, ICH stability samples and biologics. Typical scope for a walk-in cold room or ICH chamber: 9 to 15 measurement points per zone, additional points at the door, evaporator and loading boundaries, over at least a full week per campaign, with both empty (OQ) and loaded (PQ) configurations where the qualification lifecycle requires it.
- Uniformity, hot and cold spots under representative loading
- Door-open excursion depth and recovery time
- Defrost cycle impact and freezing risk near evaporator plates
- ICH conditions (25 °C / 60 % RH, 30 °C / 65 % RH, 40 °C / 75 % RH) where applicable
- Justified monitoring probe position and alarm-limit guard band
Production rooms, cleanrooms, warehouses
For controlled production environments, weighing and dispensing rooms, packaging lines, medicinal-product warehouses and cleanrooms with a temperature specification. Typical scope for a European GMP production area: a grid of loggers every 5 to 10 metres at multiple heights, over at least a full measurement week per season, with a documented rationale where a single campaign is used.
- HVAC performance, effects of air changes and heat sources under real occupancy
- Warmest and coldest product locations at floor, mid and top-rack level
- Solar and external-wall load, plus HVAC recovery after loading peaks
- Night, weekend and reduced-mode conditions
- Justified monitoring position and input to change control
Each GMP location has its own risks
Measurement points are selected based on the room type, GMP class, acceptance criteria from the URS, loading pattern and the qualification question the dossier must answer.
LocationWhat does mapping assess?Typical output
Production room / cleanroomHVAC performance, effects of air changes, heat sources, occupancy, external-wall load and night/weekend reduced mode.OQ/PQ evidence of temperature uniformity, Annex 1 impact where applicable.
Climate / stability chamberEmpty uniformity (OQ) and loaded worst case (PQ) at ICH conditions, shelf loading, door influence, recovery.Qualified product locations for stability studies, justified monitoring position.
Cold room 2-8 °CRacking, door zone, evaporator, defrost cycle, loading pattern and worst-case product locations.Qualified 2-8 °C product zones and substantiated sensor position for API or biologics.
Freezer -20 °C or ULT -80 °CDrawer and rack positions, door influence, recovery after opening, temperature gradients.Insight into worst-case zones for active substance, master cell banks and biologics.
Medicinal-product warehouseWarmest and coldest zones, seasonal impact, dispatch dock, solar load and racking height.Assessment of suitability for GMP-released or quarantined medicinal-product storage.
What does the dossier contain?
A pharma mapping dossier should make it clear why the study design was logical, how the URS and acceptance criteria drive the protocol, what the data show under real loading, and how routine monitoring and alarm limits follow from the results. That chain is what a QP signs and what an inspector reads.
"The loaded PQ made the sensor position well-supported in front of both our QP and the MHRA auditor. The alarm-limit guard band was traceable to the uncertainty of the mapping results, no assumptions."QA Manager, sterile manufacturing site
Mapping protocolScope, URS link, IQ/OQ/PQ reference, acceptance criteria and risk-based measurement setup.
Risk assessmentICH Q9 rationale for critical locations, loading and measurement points.
Measurement-point planPositions justified with reference to airflow, loading, doors, worst-case locations and product zones.
Raw data and trend graphsTemperature trend per logger, excursions, recovery data and relevant observations.
Hot/cold-spot analysisSubstantiation of warmest and coldest positions, monitoring probe location and alarm-limit guard band.
Conclusion and CAPASuitability assessment, input to change control, calibration certificates and any CAPA initiated.
See a measurement-point proposal for your own room or chamber
Before requesting a quote, use the free 3D mapping tool to sketch your production room, cold room, climate chamber or freezer. You get a proposed sensor layout, an estimated number of loggers and a first indication of the study scope, so the consultation starts with a concrete picture instead of a blank protocol page.
When to use mapping?
In GMP-relevant environments, temperature mapping is not a one-off action. Changes, audits and periodic requalification make mapping part of the regular qualification cycle.
Commissioning a new GMP facility, production room, climate chamber or cold storageHVAC modification, relocation or renovation with impact on temperature controlChange control affecting temperature-controlled equipment or utilitiesPreparation for an EMA, FDA or MHRA inspection or a customer auditPeriodic requalification per Validation Master Plan and ICH Q9 risk basisAfter a temperature deviation, excursion or OOS with unclear root causeCMO onboarding or site transfer, with sponsor-side qualification fileQualification of ICH stability chamber storage or a new stability programme
Request advice for your pharma or biotech environment
Frequently asked questions
What does GMP temperature mapping for pharma and biotech involve?
GMP temperature mapping is a documented qualification study that measures whether every product location and worst-case position inside a production room, climate chamber, cold room or freezer stays within its required temperature range over a representative period. The study identifies hot and cold spots, substantiates the representative loaded worst case, justifies the fixed monitoring probe position and alarm limits, and produces the OQ/PQ dossier that inspectors, MA-holders and Qualified Persons expect.
Is temperature mapping required under EU GMP?
Yes. EU GMP Annex 15 on qualification and validation requires documented evidence that facilities, systems and equipment consistently perform within established limits, and temperature mapping is the standard method to substantiate the OQ and PQ stages for temperature-controlled rooms and equipment. The revised EU GMP Annex 1 (in force since August 2023) adds strict expectations for HVAC performance and temperature control in classified areas. ICH Q9 (quality risk management) and Q10 (pharmaceutical quality system) frame periodic review, change control and CAPA around the mapping data. WHO TRS 961 Annex 9 (storage and transport of time- and temperature-sensitive pharmaceutical products), WHO PQS specifications and the ISPE Good Practice Guide: Controlled Temperature Chamber Mapping and Monitoring give the practical baseline for study design.
Should stability and climate chambers be mapped empty and loaded?
Yes. EU GMP Annex 15 and the ISPE Good Practice Guide: Controlled Temperature Chamber Mapping and Monitoring expect an empty-chamber study (typically part of OQ) to demonstrate intrinsic uniformity, followed by a loaded study (PQ) at representative product loading and configuration. For ICH Q1A(R2) stability chambers this means mapping at the declared condition, for example 25 °C / 60 % RH (long-term temperate), 30 °C / 65 % RH (intermediate or long-term for climatic zones III and IV) or 40 °C / 75 % RH (accelerated), with worst-case shelf loading, closed and briefly opened doors, and demonstrating recovery within acceptance criteria. Product locations that fall outside the qualified space cannot be used for stability samples.
How does temperature mapping fit into IQ, OQ and PQ under EU GMP Annex 15?
Temperature mapping is the OQ and PQ evidence in the Annex 15 qualification lifecycle. IQ verifies that the room, chamber or equipment is installed per specification and that instrumentation is calibrated and traceable. OQ demonstrates that the room or chamber performs to specification in the empty, unloaded state across the operating range and after simulated failures such as a power loss or door opening. PQ demonstrates that under real production loading, real operating hours and real routine use, all critical product locations stay within specification. The dossier explicitly traces acceptance criteria back to the URS and forward to the routine monitoring plan and alarm limits.
How often should a GMP cold room, climate chamber or freezer be re-mapped?
EU GMP does not fix a numeric interval; the frequency is defined in the Validation Master Plan on a risk basis per ICH Q9. Common practice is a full periodic re-mapping every 1 to 3 years for stable installations, with an annual documented review of the existing dossier in between. Any significant change triggers earlier requalification: HVAC modification, compressor or evaporator replacement, relocation, change in loading pattern, a repeated OOS, or a temperature excursion where root cause is not fully understood. The rationale for the chosen interval belongs in the qualification dossier and is challenged in every routine GMP inspection.
How is temperature mapping handled for a CMO or contract manufacturing site?
For a CMO or CDMO the mapping dossier serves two audiences at once: the site's own quality system and the MA-holder or sponsor's qualification file. In practice this means the URS and acceptance criteria are aligned with the product specification and the technical agreement, the mapping report is written to withstand both the CMO's internal QA review and the sponsor's audit, and any deviations trigger CAPA under joint change control. Temperature Mapping Europe delivers a report that both parties can file directly, without a rewrite for the sponsor.
What is the difference between monitoring and mapping in a GMP environment?
Monitoring runs continuously in daily operation, using one or a few fixed calibrated sensors that alarm when the room or equipment goes out of specification. Mapping is a one-off qualification study with many loggers on different positions over a representative period, executed under a protocol and reported under a signed OQ/PQ or requalification report. Mapping is what tells you where the monitoring probe belongs, which alarm limits protect the actual worst case, and what excursion behaviour to expect after a door opening or power interruption. Without mapping, monitoring positions and alarm limits cannot be defended in an inspection. See the difference between monitoring and mapping for the full comparison.
How much does GMP temperature mapping for pharma cost?
Temperature Mapping Europe offers three fixed-price levels. Level 1 (from €299) is self-execution with rented calibrated data loggers, for teams with their own protocol. Level 2 (from €599) means we prepare the mapping protocol upfront and deliver the analysis report with the mapping data afterwards, while your team places the loggers and runs the measurement on site. Level 3 (from €999) is complete on-site execution, where the mapping is performed, analysed and documented under our protocol. These prices are typically well below what larger validation consultancies quote for the same scope, because we work as a focused specialist team without the overhead of a large consultancy.
When is temperature mapping required in a pharma or biotech facility?
Mapping is required for commissioning a new GMP facility, production room, climate chamber or cold room, after HVAC modification or relocation, under change control that affects temperature control, when preparing for an EMA, FDA or MHRA inspection or a customer audit, for periodic requalification per the Validation Master Plan, after a temperature deviation or OOS with unclear root cause, when onboarding a CMO or transferring a site, and for qualification of ICH stability chamber storage or a new stability programme.